Patent Assignment
Reel/Frame 037809/0161
Intellectual Property Security Agreement
Recorded: 2016-02-12
Pages: 28
Assignor
JAGUAR ANIMAL HEALTH, INC.
Executed: 2015-08-18
Assignee
HERCULES TECHNOLGY GROWTH CAPITAL, INC., AS AGENT
400 HAMILTON AVENUE, SUITE 310, PALO ALTO, CALIFORNIA, 94301
Covered Properties
(53)
Method for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
PCT:
PCT/US2007/067725 ↗
Method for Treatment of Constipation-Predominant Irritable Bowel Syndrome
PCT:
PCT/US2007/067739 ↗
Compositions and Methods for Treating or Preventing Inflammatory Bowel Disease, Familial Adenomatous Polyposis and Colon Cancer
PCT:
PCT/US2007/067741 ↗
Methods of Treating Diseases with Proanthocyanidin Oligomers Such as Crofelemer
PCT:
PCT/US2010/051530 ↗
Methods and Compositions for Treating Hiv-Associated Diarrhea
PCT:
PCT/US2011/058549 ↗
Pharmacologically Optimized Multimodal Drug Delivery System for Nordihydroguiaretic Acid (Ndga)
PCT:
PCT/US2012/034675 ↗
Methods and Compositions for Treating Hiv-Associated Diarrhea
PCT:
PCT/US2013/032395 ↗
Methods of Treating Diarrhea in Neonatal and Young Non-Human Animals
PCT:
PCT/US2015/032899 ↗
Methods of Treating Diarrhea in Adult Non-Human Animals
PCT:
PCT/US2015/032920 ↗
Methods of Treating Salmonella-Induced Diarrhea in Non-Human Animals
PCT:
PCT/US2015/032927 ↗
Proanthocyanidin Polymers Having Antiviral Activity and Methods of Obtaining Same
Patent:
5,211,944 →
Application:
07/737,077 →
Methods for Using Proanthocyanidin Polymers Having Antiviral Activity
Patent:
5,494,661 →
Application:
08/194,779 →
Enteric Formulations of Proanthocyanidin Polymer Antidiarrheal Compositions
Application:
08/730,772 →
Enteric Formulations of Proanthocyanidin Polymer Antidiarrheal Compositions
Application:
09/066,989 →
Method of Treating Secretory Diarrhea with Enteric Formulations of Proanthocyanidin Polymer
Patent:
7,341,744 →
Application:
09/712,033 →
Enteric Formulations of Proanthocyanidin Polymer Antidiarrheal Compositions
Method for treatment of diarrhea-predominant irritable bowel syndrome
Application:
11/510,152 →
Publication:
US 2007/0254050
Method for Treatment of Constipation-Predominant Irritable Bowel Syndrome
Compositions and Methods for Treating or Preventing Inflammatory Bowel Disease, Familial Adenomatous Polyposis and Colon Cancer
Methods of treatment with proanthocyanidin polymer antidiarrheal compositions
Application:
11/998,171 →
Compositions and Methods of Treatment With Proanthocyanidin Polymer Antidiarrheal Compositions
Method for Treatment of Constipation-Predominant Irritable Bowel Syndrome
Method for Treatment of Constipation-Predominant Irritable Bowel Syndrome
Methods and Compositions for Treating Hiv-Associated Diarrhea
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application:
13/294,307 →
Publication:
US 2012/0107370
Method for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Pharmacologically Optimized Multimodal Drug Delivery System for Nordihydroguiaretic Acid (Ndga)
Methods of Treating Diseases with Proanthocyanidin Oligomers Such as Crofelemer
Application:
13/500,589 →
Publication:
US 2012/0202876
Pharmacologically Optimized Multimodal Drug Delivery System for Nordihydroguiaretic Acid (Ndga)
Compositions and Methods of Treatment with Proanthocyanidin Polymer Antidiarrheal Compositions
Application:
14/023,598 →
Publication:
US 2014/0011869
Compositions and Methods of Treatment with Proanthocyanidin Polymer Antidiarrheal Compositions
Application:
14/276,231 →
Publication:
US 2014/0329896
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application:
14/307,175 →
Publication:
US 2014/0294903
Compositions and Methods for Treating or Preventing Inflammatory Bowel Disease, Familial Adenomatous Polyposis and Colon Cancer
Method for treatment of diarrhea-predominant irritable bowel syndrome
Application:
60/797,074 →
Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
Application:
60/797,075 →
Method for treatment of constipation-predominant irritable bowel syndrome
Application:
60/797,076 →
Methods and Compositions for Treating HIV-Associated Diarrhea
Application:
61/408,622 →
Methods and Compositions for Treating HIV-Associated Diarrhea
Application:
61/409,335 →
Methods and Compositions for Treating HIV-Associated Diarrhea
Application:
61/416,249 →
Methods and Compositions for Treating HIV-Associated Diarrhea
Application:
61/434,379 →
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application:
61/734,901 →
Methods of Treating Diarrhea in Neonatal and Young Non-Human Animals
Application:
62/004,641 →
Methods of Treating Diarrhea in Adult Non-Human Animals
Application:
62/004,650 →
Methods of Treating Salmonella-Induced Diarrhea in Non-Human Animals
Application:
62/004,657 →
Methods of Treating Ulcers and Related Symptoms in Non-Human Animals
Application:
62/074,956 →
Methods of Treating Diarrhea in Neonatal and Young Non-Human Animals
Application:
62/087,203 →
Methods of Treating Diarrhea in Adult Non-Human Animals
Application:
62/087,207 →
Methods of Treating Salmonella-Induced Diarrhea in Non-Human Animals
Application:
62/087,210 →
Methods of Treating Diarrhea in Companion Animals
Application:
62/101,663 →
Methods of Treating Diarrhea in Companion Animals
Application:
62/117,927 →
Use of Croton- or Calophyllum-Derived Proanthocyanidin Polymers or Botanical Extracts in Combination with Rifaximin for the Treatment of Diarrhea in Non-Human Animals
Application:
62/121,296 →
Methods of Treating Diarrhea and Promoting Intestinal Health in Non-Human Animals
Application:
62/121,308 →
Methods of Treating Diarrhea and Promoting Intestinal Health in Non-Human Animals
Application:
62/172,573 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 15, 2012
From: CHATURVEDI, PRAVIN R.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 028211/0642 →
Assignment of Assignor's Interest
Aug 15, 2013
From: ROZHON, EDWARD JAMES; KHANDWALA, ATUL S.; SABOUNI, AKRAM; BALWANI, GUL P.
To: SHAMAN PHARMACEUTICALS, INC.
Reel/Frame 031017/0198 →
Change of Name
Aug 15, 2013
From: PS PHARMACEUTICALS, INC.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 031017/0662 →
Assignment of Assignor's Interest
Aug 15, 2013
From: SHAMAN PHARMACEUTICALS, INC.
To: PS PHARMACEUTICALS, INC.
Reel/Frame 031017/0611 →
Security Agreement
Jan 2, 2014
From: SALIX PHARMACEUTICALS, LTD.
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 031896/0752 →
Assignment of Assignor's Interest
Jan 8, 2014
From: KING, STEVEN; CHATURVEDI, PRAVIN
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 031913/0068 →
Assignment of Assignor's Interest
Jan 8, 2014
From: FORBES, WILLIAM; BORTEY, ENOCH
To: SALIX PHARMACEUTICALS, LTD
Reel/Frame 031913/0128 →
Assignment of Assignor's Interest
Jan 8, 2014
From: KING, STEVEN; CHATURVEDI, PRAVIN
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 031913/0266 →
Assignment of Assignor's Interest
Jan 8, 2014
From: FORBES, WILLIAM; BORTEY, ENOCH
To: SALIX PHARMACEUTICALS, LTD
Reel/Frame 031913/0039 →
Assignment of Assignor's Interest
Aug 1, 2014
From: TRINE PHARMACEUTICALS, INC.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 033443/0563 →
Assignment of Assignor's Interest
Aug 1, 2014
From: QUART, BARRY D.
To: NAPO PHARMACEUTICALS INC.
Reel/Frame 033443/0463 →
Assignment of Assignor's Interest
Aug 1, 2014
From: ROSENBAUM, DAVID P.; NEENAN, THOMAS X.; BLANKS, ROBERT C.
To: TRINE PHARMACEUTICALS INC.
Reel/Frame 033443/0465 →
Assignment of Assignor's Interest
Mar 16, 2015
From: ROSENBAUM, DAVID P.
To: TRINE PHARMACEUTICALS, INC.
Reel/Frame 035170/0203 →
Assignment of Assignor's Interest
Mar 16, 2015
From: ROSENBAUM, DAVID P.
To: TRINE PHARMACEUTICALS, INC.
Reel/Frame 035170/0262 →
Assignment of Assignor's Interest
Mar 16, 2015
From: TRINE PHARMACEUTICALS, INC.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 035170/0222 →
Assignment of Assignor's Interest
Mar 16, 2015
From: TRINE PHARMACEUTICALS, INC.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 035170/0265 →
Assignment of Assignor's Interest
Mar 16, 2015
From: QUART, BARRY D.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 035170/0197 →
Assignment of Assignor's Interest
Mar 16, 2015
From: QUART, BARRY D.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 035170/0246 →
Assignment of Assignor's Interest
Mar 26, 2015
From: FORBES, WILLIAM; BORTEY, ENOCH; GOLDEN, PAM
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 035264/0014 →
Release of Security Interest
Apr 1, 2015
From: JEFFERIES FINANCE LLC
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 035353/0661 →
Security Agreement
Apr 2, 2015
From: GLYCYX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 035364/0396 →
Assignment of Assignor's Interest
Mar 7, 2016
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 037910/0987 →
Assignment of Assignor's Interest
Apr 1, 2016
From: SALIX PHARMACEUTICALS, INC.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 038168/0355 →
Release of Security Interest
Jul 31, 2017
From: NANTUCKET INVESTMENTS LIMITED
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 043380/0655 →
Security Interest
Nov 22, 2017
From: NAPO PHARMACEUTICALS, INC.
To: KINGDON CAPITAL MANAGEMENT, L.L.C.
Reel/Frame 044497/0954 →